Clinical Trial Update: Rifamycin in Minimal Hepatic Encephalopathy [Phase 2]

View source ↗

Summary

Phase 2 trial update for rifamycin in minimal hepatic encephalopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatic Encephalopathy
• Liver Cirrhosis

Drugs mentioned

• rifamycin (rifamycin)

Snippet

Sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center | Conditions: Hepatic Encephalopathy, Cirrhosis, Liver | Phase 2 | Status: COMPLETED